Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells
Xanthoxyletin is a vital plant-derived bioactive coumarin. It has been shown to exhibit anticancer effects against different human cancers. Nonetheless, the anticancer effects of xanthoxyletin against human pancreatic cancer cells have not been evaluated. Against this backdrop, the present study was...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-09-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546404936974336 |
|---|---|
| author | Zhang Xin Li Luming Wu Yan |
| author_facet | Zhang Xin Li Luming Wu Yan |
| author_sort | Zhang Xin |
| collection | DOAJ |
| description | Xanthoxyletin is a vital plant-derived bioactive coumarin. It has been shown to exhibit anticancer effects against different human cancers. Nonetheless, the anticancer effects of xanthoxyletin against human pancreatic cancer cells have not been evaluated. Against this backdrop, the present study was designed to evaluate the anticancer effects of xanthoxyletin in human pancreatic cancer cells and to decipher the underlying molecular mechanisms. The results revealed a significant (p < 0.05) upregulation of receptor activator of NF-kappaB (RANK), receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) in human pancreatic tissues and cell lines at both transcriptional and translational levels. The administration of pancreatic cancer cells with xanthoxyletin diminished the viability of Capan-2 cells in a concentration-dependent manner and led to a significant decline in RANK, RANKL, and OPG expression. Silencing of RANK and xanthoxyletin treatment declined the viability of Capan-2 pancreatic cancer cells via induction of apoptosis. However, pancreatic cancer cells overexpressing RANK could rescue the growth inhibitory effects. Collectively, xanthoxyletin targets the RANK/RANKL signaling pathway in pancreatic cancer cells to induce cell apoptosis and may prove to be an important lead molecule. |
| format | Article |
| id | doaj-art-769a299953a2461fb227aa0c977eec12 |
| institution | Kabale University |
| issn | 1846-9558 |
| language | English |
| publishDate | 2023-09-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Acta Pharmaceutica |
| spelling | doaj-art-769a299953a2461fb227aa0c977eec122025-02-03T06:59:13ZengSciendoActa Pharmaceutica1846-95582023-09-0173350351310.2478/acph-2023-0024Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cellsZhang Xin0Li Luming1Wu Yan2Department of General Medicine The First People’s Hospital of Lianyungang, Lianyungang, JiangsuChinaDepartment of Neurology, The First People’s Hospital of Lianyungang Lianyungang, Jiangsu, ChinaDepartment of General Medicine The First People’s Hospital of Lianyungang, Lianyungang, JiangsuChinaXanthoxyletin is a vital plant-derived bioactive coumarin. It has been shown to exhibit anticancer effects against different human cancers. Nonetheless, the anticancer effects of xanthoxyletin against human pancreatic cancer cells have not been evaluated. Against this backdrop, the present study was designed to evaluate the anticancer effects of xanthoxyletin in human pancreatic cancer cells and to decipher the underlying molecular mechanisms. The results revealed a significant (p < 0.05) upregulation of receptor activator of NF-kappaB (RANK), receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) in human pancreatic tissues and cell lines at both transcriptional and translational levels. The administration of pancreatic cancer cells with xanthoxyletin diminished the viability of Capan-2 cells in a concentration-dependent manner and led to a significant decline in RANK, RANKL, and OPG expression. Silencing of RANK and xanthoxyletin treatment declined the viability of Capan-2 pancreatic cancer cells via induction of apoptosis. However, pancreatic cancer cells overexpressing RANK could rescue the growth inhibitory effects. Collectively, xanthoxyletin targets the RANK/RANKL signaling pathway in pancreatic cancer cells to induce cell apoptosis and may prove to be an important lead molecule.https://doi.org/10.2478/acph-2023-0024pancreatic cancercoumarinxanthoxyletinapoptosisproliferationqrt-pcr |
| spellingShingle | Zhang Xin Li Luming Wu Yan Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells Acta Pharmaceutica pancreatic cancer coumarin xanthoxyletin apoptosis proliferation qrt-pcr |
| title | Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells |
| title_full | Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells |
| title_fullStr | Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells |
| title_full_unstemmed | Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells |
| title_short | Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells |
| title_sort | xanthoxyletin blocks the rank rankl signaling pathway to suppress the growth of human pancreatic cancer cells |
| topic | pancreatic cancer coumarin xanthoxyletin apoptosis proliferation qrt-pcr |
| url | https://doi.org/10.2478/acph-2023-0024 |
| work_keys_str_mv | AT zhangxin xanthoxyletinblockstherankranklsignalingpathwaytosuppressthegrowthofhumanpancreaticcancercells AT liluming xanthoxyletinblockstherankranklsignalingpathwaytosuppressthegrowthofhumanpancreaticcancercells AT wuyan xanthoxyletinblockstherankranklsignalingpathwaytosuppressthegrowthofhumanpancreaticcancercells |